01310nam 2200361Ia 450 991069928160332120230902162112.0(CKB)5470000002401087(OCoLC)471875832(EXLCZ)99547000000240108720091201d2000 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] court decisions, ANDA approvals, and 180-day exclusivity under the Hatch-Waxman amendments to the Federal Food, Drug, and Cosmetic ActRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,[2000]1 online resource (5 pages)"Procedural.""March 2000."Guidance for industry Drug approvalUnited StatesPatent infringementGovernment policyUnited StatesDrug approvalPatent infringementGovernment policyCenter for Drug Evaluation and Research (U.S.)GPOGPOBOOK9910699281603321Guidance for industry3434577UNINA